Skip to main content
. 2020 Jun 26;43(9):zsaa123. doi: 10.1093/sleep/zsaa123

Figure 1.

Figure 1.

Study design overview. BL, baseline; EOS, end of study; LEM5, lemborexant 5 mg; LEM10, lemborexant 10 mg; PBO, placebo; SCR, screening.